Cargando…

In Vitro Activity of Rifampin, Rifabutin, and Rifapentine against Enterococci and Streptococci from Periprosthetic Joint Infection

After staphylococci, streptococci and enterococci are the most frequent causes of periprosthetic joint infection (PJI). MICs and minimum biofilm bactericidal concentrations of rifampin, rifabutin, and rifapentine were determined for 67 enterococcal and 59 streptococcal PJI isolates. Eighty-eight iso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albano, Mariana, Karau, Melissa J., Greenwood-Quaintance, Kerryl E., Osmon, Douglas R., Oravec, Caitlin P., Berry, Daniel J., Abdel, Matthew P., Patel, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Observation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552655/ https://www.ncbi.nlm.nih.gov/pubmed/34259553 http://dx.doi.org/10.1128/spectrum.00071-21

Ejemplares similares

1586. In Vitro Activity of Rifampin, Rifabutin, Rifapentine, and Rifaximin Against Biofilms Formed by Staphylococci Isolated from Prosthetic Joint Infection
por: Albano, Mariana, et al.
Publicado: (2019)

1277. Antimicrobial Resistance in Periprosthetic Joint Infection over a Decade
por: Otero, Judith Alvarez, et al.
Publicado: (2023)

Ex Vivo Human Placental Transfer of Rifampin and Rifabutin
por: Magee, Kevin P., et al.
Publicado: (1996)

Anti-biofilm activity of antibiotic-loaded Hylomate®
por: Albano, Mariana, et al.
Publicado: (2021)

1193. Human Transcriptomic Analysis of Periprosthetic Joint Infection
por: Masters, Thao, et al.
Publicado: (2020)

Successful Anticoagulation With Warfarin After Switching From Rifampin to Rifabutin
por: Alnewais, Marwah E., et al.
Publicado: (2023)

In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection
por: Cho, Hye-Kyung, et al.
Publicado: (2021)

1255. In Vitro Activity of Vancapticin against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection
por: Cho, Hye-Kyung, et al.
Publicado: (2020)

Transcriptomic analysis of Streptococcus agalactiae periprosthetic joint infection
por: Cho, Hye‐Kyung, et al.
Publicado: (2021)

Assessment of vocation of rifabutin and rifapentine in replace of rifampcin in drug resistance leprosy patients: a molecular simulation study
por: Mohanty, Partha Sarathi, et al.
Publicado: (2017)

Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice
por: Almeida, Deepak, et al.
Publicado: (2011)

A 92 protein inflammation panel performed on sonicate fluid differentiates periprosthetic joint infection from non-infectious causes of arthroplasty failure
por: Fisher, Cody R., et al.
Publicado: (2022)

693 Comparison of the 2011 Musculoskeletal Infection Society (MSIS), the 2013 International Consensus Meeting (ICM) and the Infectious Diseases Society of America (IDSA) Diagnostic Criteria for Prosthetic Joint Infection (PJI)
por: Melendez, Dante, et al.
Publicado: (2014)

Author Correction: A 92 protein inflammation panel performed on sonicate fluid differentiates periprosthetic joint infection from non-infectious causes of arthroplasty failure
por: Fisher, Cody R., et al.
Publicado: (2023)

rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis
por: Li, Ma-Chao, et al.
Publicado: (2022)

Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy
por: Chang, Yong S., et al.
Publicado: (2023)

Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy
por: Chang, Yong S., et al.
Publicado: (2023)

Methylome-dependent transformation of emm1 group A streptococci
por: Alves, Joana, et al.
Publicado: (2023)

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy
por: Lenz, Shannon M., et al.
Publicado: (2020)

Clinical Characteristics and Outcomes of Prosthetic Joint Infection Caused by Small Colony Variant Staphylococci
por: Tande, Aaron J., et al.
Publicado: (2014)

Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance
por: Darwich, Ali, et al.
Publicado: (2021)

Clinical Use of a 16S Ribosomal RNA Gene-Based Sanger and/or Next Generation Sequencing Assay to Test Preoperative Synovial Fluid for Periprosthetic Joint Infection Diagnosis
por: Flurin, Laure, et al.
Publicado: (2022)

Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study
por: Hajikhani, Bahareh, et al.
Publicado: (2021)

Improved Diagnosis of Prosthetic Joint Infection by Culturing Periprosthetic Tissue Specimens in Blood Culture Bottles
por: Peel, Trisha N., et al.
Publicado: (2016)

Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model
por: Wang, Xiaohui, et al.
Publicado: (2016)

Enterococcus faecalis Sex Pheromone cCF10 Enhances Conjugative Plasmid Transfer In Vivo
por: Hirt, Helmut, et al.
Publicado: (2018)

Exposure of Bacterial Biofilms to Electrical Current Leads to Cell Death Mediated in Part by Reactive Oxygen Species
por: Brinkman, Cassandra L., et al.
Publicado: (2016)

Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa
por: Rukasha, Ivy, et al.
Publicado: (2016)

Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial
por: Wallis, Robert S., et al.
Publicado: (2018)

In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
por: Lee, Bosul, et al.
Publicado: (2021)

Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
por: Karau, Melissa J, et al.
Publicado: (2013)

Differential Impact of the rpoB Mutant on Rifampin and Rifabutin Resistance Signatures of Mycobacterium tuberculosis Is Revealed Using a Whole-Genome Sequencing Assay
por: Yu, Ming-Chih, et al.
Publicado: (2022)

In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
por: Tong, Jiepeng, et al.
Publicado: (2021)

Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system
por: Brigante, Gioconda R, et al.
Publicado: (2007)

A Mating Procedure for Genetic Transfer of Integrative and Conjugative Elements (ICEs) of Streptococci and Enterococci
por: Iannelli, Francesco, et al.
Publicado: (2021)

Superantigen-Producing Staphylococcus aureus Elicits Systemic Immune Activation in a Murine Wound Colonization Model
por: Kim, Choon K., et al.
Publicado: (2015)

Direct Electrical Current Reduces Bacterial and Yeast Biofilm Formation
por: Ruiz-Ruigomez, Maria, et al.
Publicado: (2016)

Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine
por: McClintock, Adelaide H., et al.
Publicado: (2017)

Truth in DAIR: Duration of Therapy and the Use of Quinolone/Rifampin-Based Regimens After Debridement and Implant Retention for Periprosthetic Joint Infections
por: Tai, Don Bambino Geno, et al.
Publicado: (2022)

Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir
por: Moultrie, Harry, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_372fok88l3rfkaan82qih9qeai